Government confirms commitment to uncapped PBS in Australia

Medicines Australia welcomes the announcement of A$331 million ($236 million) for the listings of innovative medicines on the country’s Prescription Benefits Scheme (PBS) in today’s 2019/20 Federal Budget. This is reinforced by the Morrison government’s commitment to listing all positive recommendations made by the Pharmaceutical Benefits Advisory Committee.

Medicines Australia chief executive Elizabeth de Somer said: “The Morrison government has recognized that medicines matter and confirmed their commitment to the uncapped PBS and overall health expenditure. This will help ensure all Australians have access to new and innovative medicines they need when they need them.

The Treasurer announced overall health portfolio spending will increase by A$20 billion over forward estimates, from A$102 billion in 2018-19 to A$115 billion in 2022-2023. The forward estimates show a A$40 billion spend on the PBS consistent with previous years reporting.